In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
- PMID: 10639373
- PMCID: PMC89694
- DOI: 10.1128/AAC.44.2.414-417.2000
In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
Abstract
The ability of 50 sequential subcultures in subinhibitory concentrations of telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin A, roxithromycin, clindamycin, and pristinamycin to select for resistance was studied in five macrolide-susceptible and six macrolide-resistant pneumococci containing mefE or ermB. Telithromycin selected for resistance less often than the other drugs.
References
-
- Jones R N, Biedenbach D J. Antimicrobial activity of RU-66647, a new ketolide. Diagn Microbiol Infect Dis. 1997;27:7–12. - PubMed
-
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A4. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1998.
-
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. M100-S8. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1998.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
